Focus Partners Wealth’s Imunon IMNN Stock Holding History

Focus Partners Wealth’s Portfolio IMNN Stock Details IMNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,683	Closed	-$50K	–	1640
2024 Q2	$50K	Hold	2,683	–	–	﹤0.01%	1201
2024 Q1	$46K	Buy	+2,683	New	+$25.5K	﹤0.01%	973

Other funds holding IMNN

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Focus Partners Wealth's IMNN Position: Q3 2024 in Review

Focus Partners Wealth sold out of Imunon (IMNN) in Q3 2024, closing a stake of 2,683 shares — an estimated $50K sold.

Focus Partners Wealth first reported a position in IMNN in Q1 2024 and held it in 2 quarters. The position peaked at $50K in Q2 2024. 18 funds tracked by Wall St. Rank hold IMNN as of Q3 2024.

Focus Partners Wealth reported no remaining Imunon position as of Q3 2024 after selling out during the quarter.
Focus Partners Wealth sold 2,683 Imunon shares in Q3 2024, an estimated $50K.
Focus Partners Wealth first reported a position in Imunon in Q1 2024 and held it in 2 quarters.
Focus Partners Wealth's Imunon position peaked at $50K in Q2 2024.
18 funds tracked by Wall St. Rank held Imunon as of Q3 2024.

Based on Focus Partners Wealth's 13F filing for Q3 2024, filed 14 Nov 2024.